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PENYEDIAAN MIKROSFERA POLI(ASID LAKTIK) (PLA) UNTUK SISTEM 
PENGHANTARAN UBAT 
ABSTRAK 
Poli(asid laktik) (PLA) mikrosfera telah berjaya disediakan melalui kaedah emulsi dan 
pemeruapan pelarut (ESE). Taburan saiz partikel (PSD) mikrosfera yang diperoleh adalah 
dalam lingkungan 1 - 250 µm, merupakan lingkungan saiz yang boleh diterima bagi 
penghantaran jenis suntikan “parenteral”. Kaedah “shake flask” dibuktikan sebagai teknik 
alternatif untuk menentukan kebolehlaksanaan pengkapsulan sesuatu ESE sistem. Dalam 
projek ini, pasangan pelarut diklorometana-air telah digunakan dalam sistem shake flask 
untuk mensimulasikan sistem ESE, dan Rhodamine B telah digunakan sebagai model ubat 
sepanjang projek ini. Parameter yang dikaji dalam fabrikasi mikrosfera adalah kepekatan 
PLA, kepekatan PVA dan nisbah isipadu fasa teragih (DP). Kesan parameter pada PSD, 
morfologi permukaan dan kecekapan pengkapsulan telah dinilai. Formulasi optimun adalah 
pada 25% DP, 15% PLA dan 1% PVA, yang mana hasil mikrosfera tertinggi diperolehi 
dengan penggunaan PVA terendah dalam ESE sistem dan taburan partikel saiz diperolehi 
dalam 1- 50 μm. Bagi formulasi ini, pembusaan emulsi telah diperhatikan semasa 
pengacauan dalam proses pengemulsian. Dicadangkan bahawa, titisan yang tersebar dalam 
emulsi lebih cenderung berada dalam struktur buih yang seterusnya memberikan kestabilan 
tambahan antara titisan atau partikel separuh keras tersebut. Teknik hidrolisis pengaruh 
pemangkin telah digunakan untuk mengubahsuaian permukaan mikrosfera. Kajian atas 
sifat-sifat permukaan dan pukal telah dijalankan untuk mengesahkan keberkesanan teknik 
hidrolisis. Secara keseluruhan, faktor-faktor termasuk skala masa, jenis pemangkin dan 
kepekatan pemangkin harus dimanipulasi untuk mendapatkan sifat permukaan yang 
dikehendaki (contohnya, hidrofilik, caj dan morfologi permukaan) dengan ubah bentuk 
sifat pukal mikrosfera yang minimum.  
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PREPARATION OF POLY(LACTIC ACID) (PLA) MICROSPHERES FOR DRUG 
DELIVERY SYSTEM 
ABSTRACT 
Poly(lactic acid) (PLA) microspheres were fabricated through emulsion and solvent 
evaporation (ESE) technique. The particle size distributions (PSD) of microspheres 
obtained were in the range of 1- 250 µm, as within the range of acceptable size in 
parenteral injection. A shake flask method was demonstrated as an alternative technique to 
determine the encapsulation feasibility of an ESE system. Herein, dichloromethane-water 
solvent pair was used in shake flask system in order to simulate ESE system, and 
Rhodamine B was utilized as model drug throughout the project. In the fabrication of 
microspheres, the studies parameters were included PLA concentration, PVA 
concentration and dispersed phase volume ratio (DP). The effect of parameters on PSD 
range, surface morphology and encapsulation efficiency were evaluated. The optimum 
formulation was at 25 % DP, 15 % PLA and 1 % PVA, wherein the highest output of 
microspheres obtained at lowest PVA consumption in the system and narrow PSD obtained 
in range 1- 50 µm. In this formulation, extensive foaming of emulsion was observed during 
the emulsification process. It was suggested that the dispersed droplets tends to stay within 
the foam structure which further provide extra stabilization between droplets or partial 
solidified particles. The surfaces of microspheres were modified through catalytic induced 
hydrolysis technique. The surface and bulk properties of treated microspheres were 
investigated to verify the effectiveness of hydrolysis technique. Results demonstrated that 
the factors included timescale, type of catalyst and concentration should be manipulated in 
order to obtain the desired surface properties (e.g. hydrophilicity, surface charges and 
surface morphology) with minium deformation in microspheres bulk propertie
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Chapter 1 
Introduction 
1.1 Overview 
 Drug delivery system is defined as the device which encapsulated with specific 
amount of drug further delivery it in a controlled or sustained manner upon the 
administration. In pharmaceutical, it is urged to have the suitable drug delivery system that 
able to maintain the blood drug concentration lies between the minimum effective and 
maximum toxic concentration (Uchizono, 2006, Liechty et al., 2010). In order to deliver 
drugs to diseased site in the body in a more effective and less invasive way, a new dosage 
form technology of drug delivery has emerged in the late 1960’s (Coelho et al., 2010).  
 There are variable approached in designing an effective drug delivery system by 
using polymeric materials either in natural or synthetic forms. One of the promising design 
is used of biodegradable microspheres prepared from polyester, such as poly(lactic acid) 
(PLA), poly(glycolic acid) and their copolymer poly(lactic-co-glycolic). They are mostly 
focusing on the encapsulation of large molecules, e.g., peptides, proteins and plasmid 
Deoxyribo Nucleic Acid (DNA) for potential used as vaccines or as long-acting release 
drug formulation. The major advantages of biodegradable systems are they was eventually 
absorbed or excreted by the body. The drug release of microspheres was controlled by the 
polymer degradation rate and particle size of microspheres (Ulery et al., 2011). One of the 
major considerations in microspheres fabrication was the particle size distribution as it 
determined the drug administration route, drug release properties, patient compliance and 
safety during the application period (Berkland et al., 2002).  
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 Drug loaded microspheres are prepared through microencapsulation technique. 
Microencapsulation, is the term used to describe the technique to surround or coat certain 
chemical entity (in the form of either solids, liquids or gaseous) within a material that able 
to release the contents at certain conditions (upon moisture, pH, physical force or 
combination thereof) (Luzzi, 1970, Chanana et al., 2013). It has been reported that 
emulsion and solvent evaporation technique is most successful to load either insoluble or 
poorly soluble drugs in biodegradable microspheres (O'Donnell and McGinity, 1997). The 
effectiveness of microspheres preparation technique for drug delivery usage is depends on 
the successful entrapment of the drug within the particles. The understanding ESE 
technique from the aspect of intrinsic (interaction between materials) and extrinsic 
(adjustable parameters such as stirring speed, water-in-oil phase ratio, drug loading, 
polymer and stabilizer concentration) are crucial in order to produce microspheres with 
desired drug encapsulation.  
 Another consideration involved in designing an effective drug delivery system is 
the surface properties of microspheres. Generally, the surfaces of polyester based 
biodegradable microspheres are recognized as non-biocompatible because of hydrophobic 
in nature and lacking of bio-recognized functional group or molecules. These might cause 
rapid elimination of microspheres in the biological system prior drug release from 
microspheres (Stolnik et al., 1995). Material surfaces can be modified by a variety of 
different methods, such as the application of a surface chemical gradient, self-assembled 
films, surface-active bulk additive and surface chemical reaction. Microspheres surfaces 
are required to be modified with various functional groups such as methyl-, hydroxyl-, 
amino-, and carboxyl, all of which can be found on natural biological surfaces in order to 
optimize the function of microspheres as drug delivery system (Roach et al., 2007). 
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1.2 Problem Statements:   
 Emulsion and solvent evaporation (ESE) was selected as microspheres fabrication 
technique, because this technique is conceptually simple in experimental setup. However, 
the quality of microspheres (e.g. particle size, drug loading, agglomerate and etc.) prepared 
from this technique are highly dependent on the system nature. Despite the widespread use 
of this technique, encapsulation methodologies are still largely based on trial and error. 
More quantitative theory and experiments are required to improve our understanding of 
how the encapsulation conditions affect the final particle characteristics. Therefore, at the 
preliminary stage of microsphere fabrication the establishment and understanding of ESE 
technique are required.  
 The encapsulation feasibility of the ESE process is highly dependent on the 
materials interaction and the materials’ properties. As illustrated in Fig. 1.1, the feasibility 
of the system to encapsulate certain chemical substance in PLA microspheres can only be 
determined if the series of ESE process was run and the obtained microspheres were 
characterized. Therefore, an alternative approaches was proposed to determine the 
encapsulation feasibility to eliminate this trial-and-error procedure. In this research, a 
shake flask method was proposed to tackle this issue. In this shake flask approach, if the 
drug has higher affinity toward the polymer’s solvent in shake flask system, then this drug 
is able to be encapsulating within the microspheres in through ESE technique.  
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Fig. 1.1: Shake flask method proposed to replace the ESE processes during the 
determination of encapsulation feasibility 
 
 Particle size distribution of microspheres is crucial in drug delivery purposes. 
Unfortunately, the main issue of using the ESE technique in microspheres fabrication was 
the broad particle size distribution. Various approaches have been conducted to narrow the 
PSD, through either high stirring forces by homogenizer and sonication, or through highly 
controllable electrohydrodynamic atomization and membrane emulsification (Liu et al., 
2011, Vauthier and Bouchemal, 2009, Pareta and Edirisinghe, 2006, Sawalha et al., 2008). 
However, the mentioned modified techniques are required extra machinery setup or 
exposed the risk of emulsion heat up that induces the deterioration of drug (Freitas et al., 
2005). Therefore, it is desired to improve the ESE system which able to narrow the particle 
size distribution without possessing any difficulty in either the fabrication process or drug 
deterioration.  
Materials 
Polymer, Surfactant 
At least two immiscible 
solvents, Drugs 
ESE Process 
Encapsulation 
Efficiency = Feasibility 
of the system 
Characterization 
of Microspheres 
Shake Flask 
Measured the 
concentration of drug in 
each solvent phase 
Emulsification, solvent evaporation, filtering, 
washing, drying 
Shaking & Stabilization 
Alternative 
Approach 
Predict 
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 As polyester polymer are lacking active functional group to bind biomolecules, the 
stealth molecules are generally adsorbed on microspheres surface as coating to either 
improve the hydrophilicity property or introduce bio-recognized functionality (Gref et al., 
2012). However, the stealth coating formed through adsorption was unstable as it might 
easily desorbed if the environment condition was changed or varied. Therefore, it is 
desired that the surface functionalization of microspheres can be conducted in order to 
introduce active functional group and further enable the covalently crosslink with any 
biomolecules. Through the reviewing, it was noticed that microspheres are rarely modified 
through the conventional surface modification techniques, such as hydrolysis, ultraviolet 
photo-grafting, plasma radiation, and electron beam radiation (Slepička et al., 2013). In 
spite of that, it is worth exploring the potential of those conventional techniques as they 
able to diversify the surface’s functionality of microspheres. In this research, catalytic 
induced hydrolysis is selected to modify microspheres surfaces. However, it is generally 
known that hydrolysis is the major degradation mechanism of polyester. Therefore, the 
effect of hydrolysis on either improving the surface properties or deforming the bulk 
properties are required to be studied.  
1.3 Objectives: 
1. To establish the microspheres fabrication processes through the understanding of 
influencing factors in the processes.   
2. To determine the effectiveness of shake flask method to serve as alternative approach 
in predict the encapsulation feasibility of microspheres. 
3. To investigate the properties of microspheres prepared by different formulations 
through emulsion and solvent evaporation technique. 
4. To investigate the effect of catalytic induced hydrolysis in microspheres surface 
modification.  
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1.4 Research Organization  
 The research first stage involved preliminary studies, in the determination of 
materials’ concentration and the polymer solutions’ properties (e.g. viscosity, interfacial 
tension, surfactant adsorption). Shake flask method was used to select a suitable model 
drugs for PLA microspheres. The second stage of the research involved the fabrication of 
PLA microspheres at the factors of PLA concentration, PVA concentration, and dispersed 
phase volume fraction. Single emulsion was used to prepare unloaded PLA microspheres, 
while double emulsion was used to prepared model drug encapsulated microspheres. 
Microspheres properties were studied on the aspect of particle size distribution, surface 
morphology, encapsulation and loading efficiency. The release of model drug was 
conducted in condition of 37˚C and catalyzed accelerated medium. Lastly, the 
microspheres were surface modified through catalytic induced hydrolysis method, where 
the catalysts used are hydrochloride acid and sodium hydroxide. The surface and bulk 
properties of surface treated were comprehensively studied, to validate the potential of 
hydrolysis method in modified microsphere’s surfaces.   
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Chapter 2 
Literature Review 
2.1. Introduction  
 Controlled drug delivery technology represents one of the frontier areas of science 
in biopharmaceutical and biomaterials applications (Singh et al., 2010). This new dosage 
form technology of DDS has emerged in the late 1960’s in using polymers (Coelho et al., 
2010). The idea of DDS is aimed to maximize efficiency of the current available drugs, 
and further delivery drugs to diseased site in the body it in a more effective and less 
invasive way.  
 By definition, drug is the term used to describe a chemical substance that able to 
treat certain illness. The therapeutic effect of drug usage is dependent on its concentration 
in blood plasma. As shown in Fig. 2.1, the effectiveness of drug is laid within a therapeutic 
window where above the window limit will lead to toxicology effect, and below the 
window limit will loss in therapeutic effect.  
 
Fig. 2.1: Theoretical plasma concentration in conventional and controlled release drug 
delivery 
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 In conventional drug delivery (e.g. oral pills and parenteral injection), the drug 
concentration in blood plasma is rapidly increased beyond upper limit and decreases below 
lower limit of therapeutic window. The repeated uptake of drug is required at typical every 
8 hours or 24 hours along the treatment to ensure the drug concentration reached within 
therapeutic window (Shaik et al., 2012). A controlled DDS possessed advantages in 
maintained the drug concentration within the therapeutic window and sustained for longer 
period of time. The prolong drug release is able to reduce the drug administration 
frequency, and also reduced the risk of toxic effect.   
2.2 Polymeric Microspheres  
 Microspheres are characterized as the powders prepared from either nature or 
synthetic polymer having a particle size range from 1-1000 µm (Sahil et al., 2011). They 
have been routinely used in the biomedical and bioprocess applications. For example, 
polystyrene microspheres have been used in high performance liquid chromatography 
(Kirkland et al., 2000). In flow cytometry procedure, polystyrene microspheres with the 
encapsulation of fluorescent substances are typically used to calibrate the absolute number 
of specific lymphocytic cluster of differentiation cell (Zhang et al., 2009). Polyethylene 
microspheres are used as permanent or temporary fillers (Khan et al., 2012). 
Biodegradable microspheres have also been used a bulking agents in soft tissue to augment 
the efficiency of opening-closing system, which included in treatment of stress urinary 
incontinence. Furthermore, in embolization therapies which purpose to occlude blood 
vessel in assist surgical operation (Saralidze et al., 2010).  
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2.2.1 Biodegradable Microspheres 
 Biodegradable microspheres are generally acting as a drug delivery depot which 
also known as drug cargo. This type of drug delivery depot is usually formulated peptides 
or proteins in order to achieve sustain delivery that usually up to 2 - 3 years. They 
performed drug release along with the degradation of polymers and no further surgical 
removal is required after treatment completed. The long term degradation properties of 
PLA giving great opportunities in developing sustained and controlled DDS (Shaik et al., 
2012).  
 The available polymers that exhibited both biodegradable and biocompatible 
properties have included poly(lactic acid), poly(glycolic acid), polyhydroxyalkanoates, 
poly(caprolactone), poly(propylene fumarate), polyanhydrides, poly(other esters) and etc. 
Review done by Ulery et. al (2011), indicated that PLA are still the most potential 
candidates for drug delivery purposes. The predominate advantages of PLA is that there 
are commercially available and reasonable degradation rate (with degradation rate constant 
of 6.6 x 10
-6
 s
-1
). They also have largely available toxicological and chemical data, 
predictable biodegradation kinetics, ease of fabrication, versatility in properties, variety in 
copolymers ratios and molecular weights, regulatory approval (Jain, 2000, Sosnowski, 
2001, Vroman and Tighzert, 2009, Nampoothiri et al., 2010, Ulery et al., 2011).  
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2.2.2 Type of Microspheres 
 Microspheres are sometimes known as microcapsules, which are differential from 
their structural design in drug encapsulation as illustrated in Fig. 2.2. “Microcapsules” is 
used to describe the particles which contained a core (solid or liquid drug) which coated by 
a polymeric material (either single or multilayers). They also known as reservoir devices 
disregard to the size of particulates. While “microspheres” is used to describe the 
monolithic type device where the drugs molecules are dissolute or dispersed within the 
particles’ matrices (Obeidat, 2009).  
Fig.2.2: Schematic of the microcapsule (reservoir device, left) and microsphere 
(monolithic device, right) 
2.2.3 Particle Size of Microspheres 
 The common drug delivery route of microspheres was through parenteral and oral 
administration. Particle size and distribution range is one of the critical properties, as it 
greatly affected the patient compliance and safety during the application period. The 
particular considerations on microspheres’ size have been summarized and listed in Table 
2.1.  
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Table 2.1: Desirable particle size of microspheres at different administrative route and 
consideration 
Administrative Route & 
Particle Size 
Considerations 
Parenteral 
Injection 
(Intravenous, 
intramuscular , 
subcutaneous) 
< 250 µm, 
ideally < 
125 µm 
Normal needle’s size are 22 -25 gauges (inner 
diameter of 394 µm-241 µm). Patient compliance 
improved as needle size decreased. Microspheres 
size determined the needle size and the risk of 
needle blockage. (Ye et al., 2010) 
10 - 250 
µm 
Minimize the microphages phagocytosis and 
inflammatory reaction (Tabata and Ikada, 1990) 
< 100 µm 
In the case of specific organs such as the brain, 
microspheres size should not exceed 100 µm so as 
not to disturb the 3D structure of the brain (Tran et 
al., 2011) 
10 - 120 
µm 
Suitable drug depot’s size for subcutaneous or 
intramuscular delivery (Berkland et al., 2004)  
Oral 
Administration 
 
7.2 - 2.1 
µm 
Induction of mucosal immunity by particles from 5 
-10 µm. Induction of systemic and local immune 
responses by particles < 5 um (Kofler et al., 1996)  
Around 3 
µm 
Pulmonary route, microspheres should be around 3 
µm  
< 5 µm 
Particles between 3 -10 µm tends to retain in the 
Peyer’s patches of gut associated lymphoid tissue 
after oral administration. Whereas < 5 µm ease to 
across the gastro-intestinal (GI) tract and are 
progressively distributed to other sites (Yeh et al., 
1995) 
Preoperative 
embolization  
100-160 
µm 
In order to reach the precapillary arterioles (30- 160 
µm) without passing through the capillary filter (10 
-30 µm), microspheres size should be in range 100- 
160 µm. < 50 µm would be retrieved in the general 
circulation, and preferentially stopped in pulmonary 
vessels where they may cause adverse effects 
resulting either in mechanical obstruction or even in 
direct injury to the lung itself (Grandfils et al., 
1992)  
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2.3 Microspheres Fabrication 
 Microencapsulation is the term used to describe the technique used to wrap the 
chemical entities within an individual or protective coating (Chanana et al., 2013). A 
number of microencapsulation techniques have been developed included, emulsion and 
solvent evaporation/extraction, spray drying, phase separation (coacervation), atomization 
and etc. (Jain, 2000, Reis et al., 2006).  Amongst those, emulsion and solvent evaporation 
(ESE) is still being widely employed in polymeric microspheres fabrication.  
 ESE technique consists of two major processes, which is emulsification and solvent 
evaporation/removal. The flow chart in Fig. 2.3, illustrated the sequence of particles 
formation through an ESE processes (O'Donnell and McGinity, 1997). In this method, the 
pre-formed polymer is used and dissolved into it particular solvent. The drug solution or 
solid particle are firstly dispersed in the polymer solution, and then emulsified in a 
surfactant containing continuous solution. After droplets formation, the process is followed 
by solvent diffusion and evaporation from micro-droplets leading to particle formation 
(Bodmeier and McGinity, 1987, Astete and Sabliov, 2006).  
 
Fig. 2.3: Standard process in synthesis PLA microspheres by emulsion and solvent 
evaporation technique with different process options at each stage  
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2.3.1 Material Selection 
 In designing new potential drug encapsulated microspheres through ESE system, 
the considerations included are (i) the desired drugs and their chemical properties, (ii) 
polymer matrices and their chemical properties, (iii) type of emulsion system, and lastly 
(iv)the fabrication parameters and conditions. The encapsulation feasibility of the ESE 
process is measured from microspheres obtained and known as encapsulation efficiency. 
From the best of author’s knowledge, there are no alternative techniques to determine the 
encapsulation feasibility of an ESE system, except running throughout the system. 
 Numerous papers have summarized the dependency of materials usage and process 
parameters in affecting the encapsulation efficiency (Jyothi et al., 2010, Dhakar et al., 
2012, Prabu et al., 2009, Dupinder and Seema, 2013, Dhakar et al., 2010). ESE is a simple 
technique without the involvement of complicated reactions. Yet, it is very dependent on 
the nature of emulsion which comprised of various polymers, surfactant, drugs and 
solvents. The materials’ interaction has been studied from the aspects of interaction energy, 
mutual solubility and the compatibility (Liu et al., 2004, Gander et al., 1995, Matsumoto et 
al., 2008). Gander et. al (1995) have reported that the high interaction energies between 
drug-polymer-solvent is significantly reduce the encapsulation efficiency of bovine serum 
albumin in poly(lactide) microspheres. The mutual solubility acetone-water-glycerol 
reported in ternary phase diagram by Matsumoto et. al (2008) have showed to affect the 
formation poly(lactic-co-gylcolic) microspheres and encapsulation efficiency. While Liu 
et. al (2004) have highlighted polymer-drug compatibility from the aspect of enthalpy of 
mixing and partial solubility parameters, in determine the suitable polymer to encapsulate 
Ellipticine. 
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 In this project, an alternative technique is being proposed to determine the 
encapsulation feasibility of ESE without having a series of fabrication processes. The 
alternative technique is known as “shake flask” as illustrated in Fig. 2.4. It is hypothesized 
that, if the drug molecules have higher affinity to distribute in polymer’s solvent the ESE 
process will be feasible to encapsulate the drug.   
 In general, shake flask method being used in laboratory extraction or purification 
process, and also as a laboratory test in determination of partition coefficient (Log P) of the 
chemical entity. The immiscible biphasic liquids are consisted of hydrocarbon-aqueous 
pair, typically octanol-water pair since they have great difference in polarity (Sangster, 
1989). Shake flask have few similarity with emulsion, where both of the system involved 
(i) two immiscible solvents, (ii) an extractable chemical substance and (iii) create large 
interfacial area during stirring or shaking process.  
 
Fig. 2.4: The schematic illustration of shake flask 
2.3.2 Making the Emulsion 
 Emulsion is a colloidal dispersion, where a liquid is dispersed in a continuous 
liquid phase at different composition (Tadros, 2013, Schrammand, 2005). The type of 
emulsion may be distinguished according to the nature of solvent which is aqueous (water) 
and organic (oil), and their sequence of emulsification, as illustration in Fig. 2.5. 
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Fig.2.5: General type of (a) single and (b) double emulsion that able to be produced 
through ESE technique 
 
 A typical oil-in-water emulsion and description terms are showed in Fig. 2.6. 
Emulsification involved the breakage of liquid dispersed phase into dispersed droplets 
within a continuous phase. External forces are normally supplied in the emulsification, and 
these forces are sufficient to overcome the cohesive forces of liquid which allowed 
droplets formation. With the presence of surfactant, the droplets formed can be stabilized 
further solvent evaporation will led to particle formation.  
 
Fig. 2.6: Terms used in described an oil-in-water emulsion 
2.3.2.1 Stirring of Emulsion 
 In emulsification, stirring is an important parameter which controlling the size of 
microspheres. Many other factors linked to stirring also have impact on the size of 
microspheres such as the geometry of the reactor, the number of impellers and their 
position, and the ratio of impeller’s diameter compared to the reactor’s diameter (Li et al., 
2008, Puel et al., 2006). The common mechanical forces used in emulsification are 
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summarized in Table 2.2, included stirrer, homogenizer and sonicator (Walstra, 1983). 
Smaller droplet size is obtained from techniques that provide higher energy density. 
However, the solution mixture have higher tendency to be heated up and might affect the 
quality of drug.  
Table 2.2: Technique of mechanical stirring to produce emulsion 
Technique 
Droplets Mainly  
Disrupted by 
a 
Energy 
Density 
b 
Mode of 
Operation 
c 
Restrictions 
d 
Stirrer T, V L B - 
Homogenizer T, C, V H C N 
Sonicator C, T M - H C W 
 
a 
T= Turbulence, V= Viscous forces in laminar flow, C= Cavitation, 
b 
L= Low, M= Moderate, H= 
High, 
c 
D= Batch, C= Continuous, 
d 
The continuous phase should be, v= viscous, N= not so viscous, 
W=aqueous 
 
 The correlations that account the aspects of emulsion phases and factor linked to 
agitation in predict the droplet size is shown in Eq. (2.1) & (2.2) (Heiskanen et al., 2012). 
As stirring speed increases, the higher shearing forces created will thus led to smaller 
particle size. As reported in others research works, the stirring speed is always a 
dominating factor to reduced particle size as it provide shearing energy to disperse the 
dispersed phase in continuous phase (Yang et al., 2001).  
𝑑𝑚𝑎𝑥
𝐷
= 𝑐1(
𝜌𝑐 𝑁
2𝐷3
𝜎
)−0.6 =  𝑐1𝑊𝑒
−0.6                                                                               (2.1) 
𝑑32
𝐷
= 𝑐2𝑊𝑒
−0.6 =  𝑐2𝑑𝑚𝑎𝑥                                                                                             (2.2) 
Where the symbol denoted, dmax is the maximum stable droplet size, D is the diameter of 
stirrer, ρc is the density of continous phase, N is the stirring speed, We is the Weber 
Number, and lastly c1 and c2 are the coefficient of the correlation. 
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2.3.2.2 Viscosity of Solution 
 In droplets formation, the viscosity of solutions is an important factor determined 
the size of droplets. The correlation between microspheres size and solution viscosity is 
shown in Eq. (2.3) & (2.4) (Li et al., 2008, Maa and Hsu, 1996). At higher viscosity, the 
viscoelasticity forces of the solution tend to restrict the liquid breakage into droplets. The 
microspheres size increased exponentially as the dispersed phase viscosity increased.  
𝑑32 = 𝐴 (
µ𝑑
µ𝑐
)0.25                                                                                                (2.3) 
𝜏 = 𝜇 
𝑑𝜐
𝑑𝑙
= 𝜇𝛾                                                                                                 (2.4) 
Where the symbols denoted; µd is the viscosity of DP, µc is the viscosity of CP, τ  is the 
shearing forces (stress), µ is the eddy viscosity, γ is the shear rate and A is a coefficient 
that depend on many other factors. 
 In single emulsion system, the viscosity of continuous phase is desired to be higher 
as compared to dispersed phase. During the emulsification, the turbulent flow of 
continuous phase tends to produce the shearing force, acting on dispersed phase which 
encourage the liquid breakup into droplets. As the continuous phase’s viscosity increases, 
the shearing force produced also increases which able to reduced droplets size. In an oil-in-
water emulsion, the viscosity of continuous phase is generally lower than the viscosity of 
dispersed phase.  
2.3.2.3 Emulsion Phase Volume Ratio 
 Another important aspect in the emulsification is the phase volume ratio, where the 
correlation of in Eq. (2.5). In general, the increased of dispersed phase volume ratio (ϕd) 
will tend to reduce the turbulent level of the emulsification system. This will indirectly 
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reduce the shearing force of the system that used in liquid breakage, and thus resulting 
larger droplets. Furthermore, at higher ϕd condition tends to induce higher collision rates of 
droplets as there are more droplets in the continuous phase, further encouraged the 
coalescence of droplets resulting in larger particle size of microspheres (Heiskanen et al., 
2012).  
𝑑32
𝐷
=  𝑐3 ( 1 +  𝑐4𝜙𝑑)𝑊𝑒
−0.6                                                                                       (2.5) 
Where ϕd is the dispersed phase volume ratio and c3 is the coefficient of the correlation. 
2.3.2.4 Interfacial Energy 
 During droplets formation, the total interfacial area of two immiscible liquids is 
significantly increased and followed by the interfacial energy. Fig. 2.7 illustrated the 
relation between droplets size, interfacial energy and interfacial area (Schrammand, 2005). 
In the excess of energy at the droplet’s interfaces, the droplet is thermodynamically and the 
destabilization of emulsion is likely to occur. This emulsion destabilization tends to 
prepare microspheres in larger particle size. Thus, the interfacial energy has to be reduced 
in order to produce smaller particles. 
 
Fig. 2.7: Illustration of total area and energy changes involved in emulsifying one barrel of 
oil into water by dispersing into progressively finer droplets  
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 One way to reduce the interfacial energy is by the addition of surfactant into the 
emulsion system. Since surfactant is able to interact at both dispersed phase and continuous 
phase, the adsorption of surfactant at the interfaces can reduces the interfacial energy. The 
presence of small amount of surfactant is able to lower the amount of energy required for 
emulsification by several orders of magnitude (Schrammand and Stasiuk, 2006). 
Furthermore, the adsorbed layers of surfactant on interfaces are able to acting as a 
structural physical barrier to against coalescence mechanism. In general, charged surfactant 
provides stabilization through electrostatic repulsion, while for non-ionic macromolecules 
provide stabilization through steric repulsion.  
2.3.3 Stabilizing of Emulsion 
 The destabilization of droplets in an emulsion is contributed by various factors and 
the destabilization mechanisms are illustrated in Fig. 2.8.  
 Fig. 2.8 (a) illustrated the destabilization caused by the density differences caused a 
total decay of the emulsion into two layers by either creaming or sedimentation process.  
 Fig. 2.8 (b) illustrated the destabilization caused by the high attractive forces between 
droplets surfaces induced flocculation or agglomeration of the dispersed droplets.  
 Fig. 2.8 (c) illustrated the collision of droplets which further induced the coalescence 
deformation and larger droplets are formed (Damodaran, 2006).  
 Fig. 2.8 (d) illustrated destabilization by Ostwald ripening. It is a mechanism in 
minimizing the surface energy of the system where the small droplets tends to 
disappear caused by the dissolution in continuous medium, and fused with other 
droplet to form larger size droplet (Chistyakov, 2001, Filippini et al., 2012).  
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Fig. 2.8: Droplet mechanisms that lead to the deformation of an emulsion 
 
 Coalescence is a droplet deformation mechanism that involved the merging of two 
or more dispersed droplets to form a larger droplet. The coalescence rate is also depends on 
the number of droplet collisions, which dependent on the dispersed phase volume (DPV) in 
the system. DPV can also be interpreted in term of 𝜙𝑑 or droplets density in the emulsion 
system.  Fig. 2.9 is an illustration regarding of the different DPV in constant CP volume. A 
dilute emulsion contained DPV in range 0.01 - 0.3 and typically produced particle 
spherical in shape. While a mild emulsion contained DPV in range 0.2 - 0.74, the mutual 
contact between dispersed droplets might leads to the formation of dense packing particles. 
As DPV achieved ≥ 0.9, a concentrated emulsion formed and the droplets would come into 
a close contact due to room limitation. This will then leading toward coalescence process 
and forming of larger particles (Chistyakov, 2001).  
 
Fig. 2.9: Particles or droplets collision tendency a different DPV fraction 
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2.3.4 Particle Formation  
 Microspheres are obtained from the precipitation of emulsified droplets. As 
illustrated in Fig. 2.10, there are two main mass flows involved in droplets precipitation; 
solvent diffused from droplets into CP (solvent extraction) and solvents in CP diffused and 
evaporated into the air (solvent evaporation). Along the two mass flows, the droplets 
become rich in polymer and less in solvent, followed by precipitation of microspheres 
(Hwisa et al., 2013).  
 
Fig. 2.10: Illustration of solvent extraction and evaporation in droplets solidification 
2.4 Factors Influence Microspheres Properties 
 The factors which affecting the microspheres properties in ESE technique are listed 
in Table 2.3 (Freitas et al., 2005, Li et al., 2008). For materials involved in dispersed phase, 
the polymer is used as microsphere’s matrix and the soluble solvent of the polymer. The 
drug is incorporated into the polymer solution in either liquid or solid form. While 
surfactant in continuous phase is function to stabilize the droplet formed in the emulsion. 
The usage of materials in term of concentration and volume fraction is greatly affected the 
microspheres properties.  
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Table 2.3: Factors that influence the microspheres properties in ESE technique  
Factors in Emulsion and Solvent Evaporation 
Material Properties Parameters Operating Conditions 
Dispersed Phase 
Polymer 
Solvent/ co-solvent 
Drug 
Continuous Phase 
Surfactant 
Viscosity of DP and CP 
Volume fraction of DP:CP 
Drug Concentration in DP 
Concentration of polymer and 
surfactant 
Geometry of reactor and 
agitator 
Agitation rate 
Temperature 
Pressure 
 
 The studies of this project does not included the factors involved in operating 
conditions as those factors are much dependent of the laboratory equipment. The materials 
properties and the parameters which affecting the solution properties are being studied. In 
this project, the polymer and it soluble solvent are poly(lactic acid) and dichloromethane 
respectively. While, poly(vinyl alcohol) is selected as the surfactant.  
2.4.1 Poly (lactic acid) (PLA)  
 PLA is a polymer prepared from lactic acid (2-hydroxyl propionic acid). The 
usages of PLA in medical applications have been widely accepted due to their 
bioresorbable and biocompatible properties (Auras et al., 2004). PLA is versatile to be fit 
in various applications as it exists in two optical isomers -D and -L, as illustrated in Fig. 
2.11.  
 
Fig. 2.11: Chemical structure of poly(lactic acid) with (a) D-isomer, (b) L-isomer and (c) 
DL-isomer 
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 The semicrystalline structure of PLA is provided excellent mechanical strength on 
PLA’s product such as supportive implants and recovery suture. These semicrystalline 
structures of PLA have induced low degradation rate, which caused PLA taken greater than 
2 years to be completely resorbed. In advantages, the degradation rate of PLA microsphere 
is able to be adjusted from the aspect of molecular weight, crystallinity, particle size and 
porosity of structure integrity, which have make them attractive to function as a drug 
delivery system (Nampoothiri et al., 2010, Jiang et al., 2010). In the fabrication of PLA 
microspheres, it have been reported that the surface morphology of poly(D,L-lactic acid) 
microsphere is relatively smoother as compared to poly(L-lactic acid) microsphere. This 
might due to the crystalline and amorphous characteristics (Chung et al., 2001). The 
molecular weight of PLA gives significant effect on solution’s viscosity, which eventually 
producing larger size microspheres and higher loading efficiency (Benoit et al., 1999).  
2.4.2 PLA’s Solvent  
 It is important to have a suitable solvent for PLA in microspheres fabrication. 
Various solvents such as dioxane, acetonitrile, chloroform, methylene chloride, 1,1,2-
trichloroethane and dichloroacetatic acid are reported as PLA solvent’s. The solubility of 
PLA is dependent on their characteristic (e.g. molecular weight, stereoisomerism, and 
crystallinity). In general, amorphous PLA is soluble in most organic solvents, such as 
tetrahydrofuran, chlorinated solvents, benzene, acetonitrile and dioxane (Garlotta, 2001). 
While, crystalline poly(L-lactide) is not soluble in acetone, ethyl acetate or tetrahydrofuran, 
however, it is able to be dissolved at boiling temperature (Nampoothiri et al., 2010).  
 The general considerations in solvent selection included PLA soluble, poorly 
soluble in continuous phase, highly volatile with low boiling point, and low toxicity (Li et 
al., 2008). Dichloromethane (DCM) is commonly used as PLA’s solvent in PLA 
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microspheres fabrication. The properties of DCM are listed in Table 2.4. It contained low 
boiling point (40˚C) that promise a fast evaporation rate during microspheres precipitation. 
DCM is a suitable solvent to dissolve semicrystalline PLA at higher dissolution rate, due to 
their relative small “molar volume” (Auras et al., 2010, Jin et al., 2010, Abbott, 2010).  
Table 2.4: Chemical properties of dichloromethane (Millipore, 2014) 
Molecular Structure Solvent Properties 
 
Molar Mass 84.94 g/mol 
Boiling Point 40 ˚C 
Density (20˚C) 1.33 g/cm3 
Vapour Pressure (20˚C) 475 hPa 
Water Solubility (20˚C) 20 g/L 
Refractive Index 1.42 
 
 In polyester-based microspheres fabrication, ethyl acetate has been used to replace 
DCM as the more biocompatible solvent (Sah, 1997). However, the encapsulation 
efficiency of microspheres is significantly reduced with the use ethyl acetate (Herrmann 
and Bodmeier, 1995). Besides, several kind of organic solvents with greater polarity than 
dichloromethane such as acetone, n-butyl alcohol and ether have been used as replacement 
solvent or co-solvent in the emulsion system. By using this higher polarity solvent 
promoting rapid solvent diffusion into the continuous phase, resulting the rapid 
precipitation microspheres in the system. Zhang et. al (2013) reported the used  of  acetone 
as co-solvent in DCM have prepared PLA microspheres with higher encapsulation 
efficiency and absence of emamectin benzoate on microspheres’ surfaces. On the other 
hand, as polymer having high solubility in a solvent, droplet took longer duration to 
solidify. As the precipitation time increases, the duration of polymer droplets stayed in 
semi-solid state is extended and resulted higher diffusion of drug into continuous phase. 
This will reduce the encapsulation efficiency of microspheres (Dhakar et al., 2012). 
